Psychiatry and Neurology, Neurology · Nashville, TN
NPI
1548344658
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3601 Tvc
Nashville, TN, 37232
Phone (615) 322-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$14K
214 services
Medicare patients, 2024
114
Average age 63
Drug cost, 2024
$3.4M
2,207 prescriptions
Company payments, 2025
$3,505
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Subramaniam Sriram was code 99214 (office e&m - established), 93 times for 80 patients. In total Subramaniam Sriram billed 214 services in 5 codes, and Medicare paid $14K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 93 | 80 | $57.54 | $5,351 |
| 99215 Office E&M - Established | Office | 72 | 49 | $94.07 | $6,773 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 26 | 24 | $12.93 | $336 |
| 99213 Office E&M - Established | Office | 16 | 16 | $47.25 | $756 |
By year: 2022 $15K for 207 services; 2023 $12K for 181 services; 2024 $14K for 214 services.
Medicare prescription drug claims, 2024
In 2024, the drug Subramaniam Sriram prescribed most often to Medicare patients was Baclofen, with 299 prescriptions and refills. In total Subramaniam Sriram wrote 2,207 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Baclofen Generic | 299 | 515 | 69 | $6,114 |
| Gabapentin Generic | 204 | 330 | 59 | $4,123 |
| Dalfampridine Er Dalfampridine | 135 | 211 | 25 | $86K |
| Diazepam Generic | 122 | 122 | 24 | $1,170 |
| Modafinil Generic | 89 | 111 | 20 | $5,171 |
| Kesimpta Pen Ofatumumab | 84 | 93 | Under 11 | $830K |
| Fingolimod Fingolimod Hcl | 71 | 85 | Under 11 | $113K |
| Tizanidine Hcl Generic | 48 | 92 | 17 | $775 |
| Oxcarbazepine Generic | 48 | 82 | 11 | $2,789 |
| Mycophenolate Mofetil Generic | 47 | 65 | Under 11 | $3,476 |
| Avonex (4 Pack) Interferon Beta-1a | 38 | 38 | Under 11 | $297K |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 34 | 34 | 11 | $879 |
| Gilenya Fingolimod Hcl | 33 | 41 | Under 11 | $337K |
| Desmopressin Acetate Generic | 31 | 47 | Under 11 | $910 |
| Oxybutynin Chloride Generic | 29 | 51 | Under 11 | $317 |
Brand drugs: 378 claims; generic drugs: 1,829 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Subramaniam Sriram $3,505 ($3,505 in general payments such as food, travel and fees) from 5 companies. The largest payer was TG Therapeutics, Inc. with $3,327.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.